Stockreport

Trevi Therapeutics launches $150M public stock offering [Seeking Alpha]

Trevi Therapeutics, Inc.  (TRVI) 
PDF The company also plans to grant underwriters a 30-day option to purchase up to an additional $22.5M in shares. Proceeds will support development of Haduvio (oral nalb [Read more]